← Back to patent-cliff list
Bevantolol-hydrochloride (SOM Biotech)
Tier C — Watch / tradeBevantolol-hydrochloride (SOM Biotech)
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：ADRB1, VMAT2
Indications (approved)：亨廷顿舞蹈症
Regional status
US
-
EU
Phase II
2018-08-08
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Bevantolol-hydrochloride (SOM Biotech)?
Approved indications include: 亨廷顿舞蹈症.
When does the Bevantolol-hydrochloride (SOM Biotech) patent expire?
No public expiry year is available for Bevantolol-hydrochloride (SOM Biotech) yet; this page updates once verified.
How do I get a quote for Bevantolol-hydrochloride (SOM Biotech) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-08